Bifidobacterium breve
- Generic Name
- Bifidobacterium breve
- Drug Type
- Biotech
- Unique Ingredient Identifier
- L07O8T40TE
Cytokine Profile in Children With Celiac Disease
Phase 1
Completed
- Conditions
- Celiac Disease
- Interventions
- First Posted Date
- 2014-09-18
- Last Posted Date
- 2014-09-18
- Lead Sponsor
- University Medical Centre Maribor
- Target Recruit Count
- 66
- Registration Number
- NCT02244047
Effect of Bifidobacterium on Irritable Bowel Syndrome
Not Applicable
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-08-20
- Last Posted Date
- 2008-08-20
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 50
- Registration Number
- NCT00737841
- Locations
- 🇯🇵
Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath